• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROSA VALVE; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROSA VALVE; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV701T
Device Problem Infusion or Flow Problem (2964)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 01/17/2020
Event Type  Injury  
Manufacturer Narrative
Height: 130cm.Visual inspection no significant deformations or damage of the valves were detected during the visual inspection.Permeability test: a permeability test has shown that the valve is permeable.Adjustment test: the adjustment test has shown that the prosa is adjustable to all settings, even if high pressure was necessary.Braking force and brake function test: the investigation of the braking force of the prosa valve showed that the brake function is fully operational.However, the braking force was out of tolerance.Computer controlled test: the test is performed with a miethke computer controlled testing apparatus.The valve was tested by simulating a cerebrospinal fluid flow at rates between 60 ml/h down to 5 ml/h and up again to 60 ml/h in the vertical and horizontal position (in acc.To iso 7197).Distilled water is used as test-liquid.The opening pressure is expected to measure at the reference flow rate 0 ± 4 cmh2o in the vertical position.Results first, we performed a visual inspection of the valves.No significant deformations or damages of the valve was detected during the visual inspection.Further, we tested the permeability of the valve.The test has shown that the valve was permeable.The testing of the adjustability, the brake functionality and as well the brake force of the prosa valve was possible.Except of the braking force, the test values were within the expected tolerances.To investigate the suspicion of an over-drainage, the opening pressure is measured by using a miethke computer controlled testing apparatus, which simulates a cerebrospinal fluid flow.The prosa is tested in the vertical position.The opening pressure in the vertical position at a reference flow level of 5 ml/h was measured at -7,68 cmh2o.The valve is not operating within the acceptable tolerance [tolerance 0 ± 4 cmh2o].A second test was done.The opening pressure in the second test was measured at -7, 16 cmh2o.There was no significant improvement in the values.Finally, we have dismantled the valve.Inside the valve, we have found a build-up of substances (likely protein.Based on our investigation, we can confirm that the prosa valve is over-draining, likely due to build-up of protein deposits.As described in scientific literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.Nevertheless, we can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.
 
Event Description
It was reported that a valve is over draining.The reporter indicated that a post-operative valve is operating in over drainage and required explantation.Additional event details were not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROSA VALVE
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM   14469
Manufacturer Contact
joerg knebel
2 ulanenweg
potsdam d, 14469
GM   14469
MDR Report Key9681656
MDR Text Key178262741
Report Number3004721439-2020-00036
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K120559
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/26/2021
Device Model NumberFV701T
Device Catalogue NumberFV701T
Device Lot Number20032101
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/21/2020
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/21/2020
Initial Date FDA Received02/07/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/28/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age10 YR
Patient Weight50
-
-